Medpace Holdings Inc (MEDP) - Total Liabilities

Latest as of March 2026: $1.53 Billion USD

Based on the latest financial reports, Medpace Holdings Inc (MEDP) has total liabilities worth $1.53 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Medpace Holdings Inc (MEDP) net asset momentum to track the company's year-over-year net asset growth rate.

Medpace Holdings Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Medpace Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Medpace Holdings Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Medpace Holdings Inc Competitors by Total Liabilities

The table below lists competitors of Medpace Holdings Inc ranked by their total liabilities.

Company Country Total Liabilities
Albemarle Corp
NYSE:ALB
USA $5.03 Billion
VODACOM GROUP LTD. SP.ADR
F:5VD0
Germany €146.48 Billion
Circle Internet Group, Inc.
NYSE:CRCL
USA $75.38 Billion
Henkel AG & Co. KGaA vz. (Pref Shares)
XETRA:HEN3
Germany €12.67 Billion
Grupo Financiero Inbursa S.A.B. de C.V
MX:GFINBURO
Mexico MX$570.81 Billion
BSE Limited
NSE:BSE
India Rs57.74 Billion
Yum China Holdings Inc
NYSE:YUMC
USA $4.73 Billion
HAIER SM.HME UNSP.ADR/4
F:HAI0
Germany €165.78 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Medpace Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Medpace Holdings Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.56 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.72 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medpace Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medpace Holdings Inc (2014–2025)

The table below shows the annual total liabilities of Medpace Holdings Inc from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 $1.52 Billion +18.90%
2024-12-31 $1.28 Billion +16.16%
2023-12-31 $1.10 Billion +13.64%
2022-12-31 $966.11 Million +36.65%
2021-12-31 $707.01 Million +20.88%
2020-12-31 $584.90 Million +40.33%
2019-12-31 $416.79 Million +10.19%
2018-12-31 $378.23 Million -15.42%
2017-12-31 $447.19 Million +21.39%
2016-12-31 $368.39 Million -35.43%
2015-12-31 $570.57 Million -17.90%
2014-12-31 $694.94 Million --

About Medpace Holdings Inc

NASDAQ:MEDP USA Diagnostics & Research
Market Cap
$16.87 Billion
Market Cap Rank
#1623 Global
#625 in USA
Share Price
$590.67
Change (1 day)
+0.97%
52-Week Range
$393.42 - $620.59
All Time High
$620.59
About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medica… Read more